Northwestern University: Melanoma trials
The registry lists 16 Melanoma studies with Northwestern University as lead sponsor. 1 are open to participants now and 5 have results posted.
Early Phase 1 1Phase 1 3Phase 2 1No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Sun Exposure and Activities After Skin Cancer: Optimization of mHealth InterventionsRecruitingNCT07556380Not applicable
- Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician AccessCompletedNCT04420273Not applicableResults posted
- Skin Self-Examination Education During MammographyCompletedNCT03512457Not applicableResults posted
- Melanoma Perception and Health Literacy in People of ColorCompletedNCT02437305Not applicableResults posted
- Partner Assistance in Learning and Performing Skin Self-ExaminationCompletedNCT01013844Not applicableResults posted
- Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic MelanomaCompletedNCT00301067Phase 1/2Results posted
- Teaching Skin Self-Examination to First-degree Relatives of Melanoma Patients Using Mobile App TechnologyWithdrawnNCT03177941Not applicable
- Promoting Early Detection of Melanoma During the Mammography ExperienceCompletedNCT03057327Not applicable
- Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check PartnersCompletedNCT02854657Not applicable
- Training Primary Care Physicians to Perform Melanoma Opportunistic SurveillanceCompletedNCT02385253Not applicable
- Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of MelanomaCompletedNCT01859845Not applicable
- A Comparison of Interventions to Teach Melanoma Patients Skin Self-examinationCompletedNCT01432860Not applicable
- Evaluation of a Simulation Training Tool to Identify Lesions Requiring Further Screening for MelanomaCompletedNCT01191294Not applicable
- A Novel Treatment for Metastatic MelanomaTerminatedNCT00758797Phase 1
- Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerCompletedNCT00276835Early Phase 1
- Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWithdrawnNCT00006126Phase 1